DOI:
10.1055/s-00049561
South Asian Journal of Cancer
LinksClose Window
References
Chapman PB, Hauschild A, Robert C. et al
BRIM-3 Study Group. Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
N Engl J Med 2011;
364 (26) 2507-2516
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.